Identification of Overexpressed Genes in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is a fatal tumor lacking effective therapies. The characterization of overexpressed genes could constitute a strategy for identifying drivers of tumor progression as targets for novel therapies. Thus, we performed an integrated gene-expression analysis on RNAseq...

Full description

Bibliographic Details
Main Authors: Federica Morani, Luisa Bisceglia, Giulia Rosini, Luciano Mutti, Ombretta Melaiu, Stefano Landi, Federica Gemignani
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/5/2738
_version_ 1797542141115760640
author Federica Morani
Luisa Bisceglia
Giulia Rosini
Luciano Mutti
Ombretta Melaiu
Stefano Landi
Federica Gemignani
author_facet Federica Morani
Luisa Bisceglia
Giulia Rosini
Luciano Mutti
Ombretta Melaiu
Stefano Landi
Federica Gemignani
author_sort Federica Morani
collection DOAJ
description Malignant pleural mesothelioma (MPM) is a fatal tumor lacking effective therapies. The characterization of overexpressed genes could constitute a strategy for identifying drivers of tumor progression as targets for novel therapies. Thus, we performed an integrated gene-expression analysis on RNAseq data of 85 MPM patients from TCGA dataset and reference samples from the GEO. The gene list was further refined by using published studies, a functional enrichment analysis, and the correlation between expression and patients’ overall survival. Three molecular signatures defined by 15 genes were detected. Seven genes were involved in cell adhesion and extracellular matrix organization, with the others in control of the mitotic cell division or apoptosis inhibition. Using Western blot analyses, we found that ADAMTS1, PODXL, CIT, KIF23, MAD2L1, TNNT1, and TRAF2 were overexpressed in a limited number of cell lines. On the other hand, interestingly, CTHRC1, E-selectin, SPARC, UHRF1, PRSS23, BAG2, and MDK were abundantly expressed in over 50% of the six MPM cell lines analyzed. Thus, these proteins are candidates as drivers for sustaining the tumorigenic process. More studies with small-molecule inhibitors or silencing RNAs are fully justified and need to be undertaken to better evaluate the cancer-driving role of the targets herewith identified.
first_indexed 2024-03-10T13:26:27Z
format Article
id doaj.art-c7a9346552b14159aa0b065b5ed3d0e5
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T13:26:27Z
publishDate 2021-03-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c7a9346552b14159aa0b065b5ed3d0e52023-11-21T09:38:45ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-03-01225273810.3390/ijms22052738Identification of Overexpressed Genes in Malignant Pleural MesotheliomaFederica Morani0Luisa Bisceglia1Giulia Rosini2Luciano Mutti3Ombretta Melaiu4Stefano Landi5Federica Gemignani6Department of Biology, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, University of Pisa, 56126 Pisa, ItalyCenter for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, PA 19122, USADepartment of Biology, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, University of Pisa, 56126 Pisa, ItalyDepartment of Biology, University of Pisa, 56126 Pisa, ItalyMalignant pleural mesothelioma (MPM) is a fatal tumor lacking effective therapies. The characterization of overexpressed genes could constitute a strategy for identifying drivers of tumor progression as targets for novel therapies. Thus, we performed an integrated gene-expression analysis on RNAseq data of 85 MPM patients from TCGA dataset and reference samples from the GEO. The gene list was further refined by using published studies, a functional enrichment analysis, and the correlation between expression and patients’ overall survival. Three molecular signatures defined by 15 genes were detected. Seven genes were involved in cell adhesion and extracellular matrix organization, with the others in control of the mitotic cell division or apoptosis inhibition. Using Western blot analyses, we found that ADAMTS1, PODXL, CIT, KIF23, MAD2L1, TNNT1, and TRAF2 were overexpressed in a limited number of cell lines. On the other hand, interestingly, CTHRC1, E-selectin, SPARC, UHRF1, PRSS23, BAG2, and MDK were abundantly expressed in over 50% of the six MPM cell lines analyzed. Thus, these proteins are candidates as drivers for sustaining the tumorigenic process. More studies with small-molecule inhibitors or silencing RNAs are fully justified and need to be undertaken to better evaluate the cancer-driving role of the targets herewith identified.https://www.mdpi.com/1422-0067/22/5/2738malignant pleural mesotheliomaMPMRNAseqgene signatureoverexpressed genestherapeutic targets
spellingShingle Federica Morani
Luisa Bisceglia
Giulia Rosini
Luciano Mutti
Ombretta Melaiu
Stefano Landi
Federica Gemignani
Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
International Journal of Molecular Sciences
malignant pleural mesothelioma
MPM
RNAseq
gene signature
overexpressed genes
therapeutic targets
title Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
title_full Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
title_fullStr Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
title_full_unstemmed Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
title_short Identification of Overexpressed Genes in Malignant Pleural Mesothelioma
title_sort identification of overexpressed genes in malignant pleural mesothelioma
topic malignant pleural mesothelioma
MPM
RNAseq
gene signature
overexpressed genes
therapeutic targets
url https://www.mdpi.com/1422-0067/22/5/2738
work_keys_str_mv AT federicamorani identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT luisabisceglia identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT giuliarosini identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT lucianomutti identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT ombrettamelaiu identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT stefanolandi identificationofoverexpressedgenesinmalignantpleuralmesothelioma
AT federicagemignani identificationofoverexpressedgenesinmalignantpleuralmesothelioma